United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Healthcare Industry News Breakthrough in kidney cancer imaging: FDA fast-tracks Telix Pharmaceuticals’ TLX250-CDx The United States Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for Telix Pharmaceuticals… byPallavi MadhirajuFebruary 26, 2025